Citation Impact
Citing Papers
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
2018 Standout
Non-steroidal anti-inflammatory drugs for low back pain
2008
Nonsteroidal Anti-Inflammatory Drugs for Low Back Pain
2008
Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: A six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug
2001
Non-specific low back pain
2016 Standout
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
2017 Standout
Ankylosing spondylitis
2007 Standout
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
2002 Standout
Meloxicam
1996
A review of the biomaterials technologies for infection-resistant surfaces
2013 Standout
How to diagnose axial spondyloarthritis early
2004
Rheumatoid arthritis
2010 Standout
The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
2010 Standout
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
2008 Standout
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view
2017 Standout
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
2009 Standout
COX-2 inhibitors
1999 Standout
Assessments in ankylosing spondylitis
2006
Ankylosing spondylitis: an overview
2002
epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England
2013 Standout
The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria?
2005 Standout
Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline
2017
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Chapter 4European guidelinesfor the management of chronicnonspecific low back pain
2006 Standout
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
2008
Works of Patrick Vélicitat being referenced
Tolerability of Multiple Administration of Intramuscular Meloxicam: A Comparison with Intramuscular Piroxicam in Patients with Rheumatoid Arthritis or Osteoarthritis
1996
Oral meloxicam is effective in acute sciatica: two randomised, double-blind trials versus placebo or diclofenac
2001
Comparison of intramuscular and oral meloxicam in rheumatoid arthritis patients
2001
Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis.
1999
Comparison of the onset and intensity of action of intramuscular meloxicam and oral meloxicam in patients in acute sciatica
1995